Tags

Type your tag names separated by a space and hit enter

Pharmacological treatment options for autism spectrum disorders in children and adolescents.
Harv Rev Psychiatry. 2008; 16(2):97-112.HR

Abstract

Autism and other pervasive developmental disorders (PDDs) are frequently associated with dysfunctional behaviors and are characterized by deficits in socialization, communication, and behavioral rigidity. Despite the absence of a pharmacological cure for PDDs, many of the dysfunctional, coinciding behaviors may be treated pharmacologically. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from autistic spectrum disorders.

Authors+Show Affiliations

Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18415882

Citation

Leskovec, Thomas J., et al. "Pharmacological Treatment Options for Autism Spectrum Disorders in Children and Adolescents." Harvard Review of Psychiatry, vol. 16, no. 2, 2008, pp. 97-112.
Leskovec TJ, Rowles BM, Findling RL. Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harv Rev Psychiatry. 2008;16(2):97-112.
Leskovec, T. J., Rowles, B. M., & Findling, R. L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harvard Review of Psychiatry, 16(2), 97-112. https://doi.org/10.1080/10673220802075852
Leskovec TJ, Rowles BM, Findling RL. Pharmacological Treatment Options for Autism Spectrum Disorders in Children and Adolescents. Harv Rev Psychiatry. 2008;16(2):97-112. PubMed PMID: 18415882.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pharmacological treatment options for autism spectrum disorders in children and adolescents. AU - Leskovec,Thomas J, AU - Rowles,Brieana M, AU - Findling,Robert L, PY - 2008/4/17/pubmed PY - 2008/5/6/medline PY - 2008/4/17/entrez SP - 97 EP - 112 JF - Harvard review of psychiatry JO - Harv Rev Psychiatry VL - 16 IS - 2 N2 - Autism and other pervasive developmental disorders (PDDs) are frequently associated with dysfunctional behaviors and are characterized by deficits in socialization, communication, and behavioral rigidity. Despite the absence of a pharmacological cure for PDDs, many of the dysfunctional, coinciding behaviors may be treated pharmacologically. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from autistic spectrum disorders. SN - 1465-7309 UR - https://www.unboundmedicine.com/medline/citation/18415882/Pharmacological_treatment_options_for_autism_spectrum_disorders_in_children_and_adolescents_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=18415882.ui DB - PRIME DP - Unbound Medicine ER -